Blog
News February 23, 2021
 AbSci Announces Strategic Investment
– AbSci announced a strategic equity investment by Merck Global Health Innovation Fund. – Merck GHI is a fund of Merck Research Laboratories. – AbSci is a leading synthetic biology company that translates ideas into drugs with a revolutionary platform technology that reinvents the biopharmaceutical drug discovery process.
News February 22, 2021
 Creatio raises $68 million for low-code enterprise process automation
News February 20, 2021
 Digital Engagement Platform Symend Raises $43 Million Series B Extension
News February 20, 2021